Nirogacestat Hydrobromide Patent Expiration
Nirogacestat Hydrobromide is Used for treating adult patients with progressing desmoid tumors. It was first introduced by Springworks Therapeutics Inc
Nirogacestat Hydrobromide Patents
Given below is the list of patents protecting Nirogacestat Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ogsiveo | US11872211 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11925619 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11925620 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11938116 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11951096 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11957662 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US12011434 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US12011435 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US12036207 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US12138246 | Treatments with nirogacestat | May 19, 2043 | Springworks |
| Ogsiveo | US11807611 | Chlorinated tetralin compounds and pharmaceutical compositions | Sep 08, 2042 | Springworks |
| Ogsiveo | US11844780 | Chlorinated tetralin compounds and pharmaceutical compositions | Sep 08, 2042 | Springworks |
| Ogsiveo | US11504354 | Chlorinated tetralin compounds and pharmaceutical compositions | Jul 08, 2042 | Springworks |
| Ogsiveo | US11612588 | Chlorinated tetralin compounds and pharmaceutical compositions | Jul 08, 2042 | Springworks |
| Ogsiveo | US12110277 | Synthesis of nirogacestat | Jul 08, 2042 | Springworks |
| Ogsiveo | US12234210 | Synthesis of nirogacestat | Jul 08, 2042 | Springworks |
| Ogsiveo | US12247012 | Synthesis of nirogacestat | Jul 08, 2042 | Springworks |
| Ogsiveo | US10590087 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US10710966 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US10941118 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11820748 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11845732 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11884634 | Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide | Aug 09, 2039 | Springworks |
| Ogsiveo | US11884635 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US11905255 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US12116347 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US12297177 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Aug 09, 2039 | Springworks |
| Ogsiveo | US7795447 | Imidazole compounds for the treatment of neurodegenerative disorders | Aug 18, 2030 | Springworks |
| Ogsiveo | US7342118 | Imidazole compounds for the treatment of neurodegenerative disorders |
Aug 18, 2025
(Expired) | Springworks |
| Ogsiveo | US7951958 | Imidazole compounds for the treatment of neurodegenerative disorders |
Mar 11, 2025
(Expired) | Springworks |
Nirogacestat Hydrobromide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List